Author:
Jonkman-de Vries Jantine D.,Talsma Herre,Henrar Roland E. C.,Kettenes-van den Bosch Jantien J.,Bult Auke,Beijnen Jos H.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference16 articles.
1. Bailey SM, Friedlos F, Knox RJ, Workman P (1992) Bioreductive activation of indoloquinone EO9: involvement of DT-diaphorase and DNA crosslinking. Ann Oncol 3: 185
2. Bailey SM, Suggett N, Walton MI, Workman P (1992) Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones. Int J Radiat Oncol Biol Phys 22: 649
3. Binger M, Workman P (1990) Gradient high-performance liquid chromatographic assay for the determination of the novel indoloquinone antitumour agent EO9 in biological specimens. J Chromatogr 532: 321
4. Cammack KA, Adams GDJ (1985) Formulation and storage. Anim Cell Biotechnol 3: 251
5. Davignon JP, Slack JA, Beijnen JH, Vezin WR, Schoemaker TJ (1988) EORTC/CRC/NCI guidelines for the formulation of investigational cytotoxic drugs. Eur J Cancer Clin Oncol 24: 1535
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献